Adverse events were classified by severity as mild (easily tolerated, causing minimal discomfort, and not interfering with everyday activities), moderate (causes sufficient discomfort and interferes with normal everyday activities), or severe (prevents normal everyday activities)
As metabolic research advances, peptides targeting incretin and appetite-regulating pathways have become a central focus in the study of obesity, glucose regulation, and energy balance
GLP-1 as a trend has grown by 1054% in social discussion over the past year, according to Tastewise, a GenAI-powered consumer data platform (see graph below)
Drug levels are low enough that appetite suppression is minimal
The dose can be gradually increased up to a maximum of 15 mg weekly based on your needs and tolerance